Experimental group:Zhuifengtougu Capsules
Sponsors
Temporarily not sure
Conditions
Cervical spondylosisLumbar disc herniationOsteoarthritisPeriarthritis of shoulderRheumatoid Arthritis
Phase 4
Re-evaluation of Zhui-Feng Tou-Gu capsule in the treatment of Osteoarthritis after marketing
RecruitingChiCTR2000028809
Start: 2020-01-01Updated: 2022-03-07
Post-marketing reevaluation of Zhuifeng Tougu capsule in treating Rheumatoid Arthritis
RecruitingChiCTR2000028806
Start: 2020-01-01Updated: 2022-03-07
Re-evaluation of Zhuifengtougu capsule in the treatment of scapulohumeral periarthritis
RecruitingChiCTR2000028808
Start: 2020-01-01Updated: 2022-03-07
Post-market re-assessment for Zhui-Feng Tou-Gu capsule in the treatment of lumbar disc herniation
Active, not recruitingChiCTR2000028794
Start: 2020-01-01Updated: 2022-03-07
Re-evaluation of Zhuifengtougu capsule in the treatment of cervical spondylosis
RecruitingChiCTR2000028807
Start: 2020-01-01Updated: 2022-03-07
Re-evaluation of Zhui-Feng Tou-Gu capsule in the treatment of Osteoarthritis after marketing
RecruitingITMCTR2000002898
Start: 2020-01-01Updated: 2023-02-20
Post-market re-assessment for Zhui-Feng Tou-Gu capsule in the treatment of lumbar disc herniation
Active, not recruitingITMCTR2000002894
Start: 2020-01-01Updated: 2023-02-20
Post-marketing reevaluation of Zhuifeng Tougu capsule in treating Rheumatoid Arthritis
RecruitingITMCTR2000002895
Start: 2020-01-01Updated: 2023-02-20
Re-evaluation of Zhuifengtougu capsule in the treatment of cervical spondylosis
RecruitingITMCTR2000002896
Start: 2020-01-01Updated: 2023-02-20
Re-evaluation of Zhuifengtougu capsule in the treatment of scapulohumeral periarthritis
RecruitingITMCTR2000002897
Start: 2020-01-01Updated: 2023-02-20